EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study

Sai Rahul Ponnana, Nik Surya, Feriel Presswalla, Gokul Parameswaran, Yuvraj Narang, Tong Zhang, Zhuo Chen, Jean-Eudes Dazard, Santosh Kumar Sirasapalli, Kanimozhi Sivanantham, Robert Okyere, Shamsa Elhussain und 3 weitere

American Journal of Preventive Cardiology · 2026-08 · 28 · 101543

DOI: 10.1016/j.ajpc.2026.101543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-08. Verfasst von Sai Rahul Ponnana und 14 weiteren Autor:innen. Beteiligte Einrichtung: Case School of Medicine, Case Western Reserve University, Cleveland, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Case School of Medicine, Case Western Reserve University, Cleveland, USA.
  • Harrington Heart and Vascular Institute University Hospitals, Cleveland, USA.
  • Louis Stokes Cleveland VA Medical Center, Cleveland, USA.
  • School of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Zitieren

APA

Ponnana, S. R., Surya, N., Presswalla, F., Parameswaran, G., Narang, Y., Zhang, T., Chen, Z., Dazard, J. E., Sirasapalli, S. K., Sivanantham, K., Okyere, R., Elhussain, S., Neeland, I. J., Rajagopalan, S., & Deo, S. V. (2026). Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study. American Journal of Preventive Cardiology, 28, 101543. https://doi.org/10.1016/j.ajpc.2026.101543

Vancouver

Ponnana SR, Surya N, Presswalla F, Parameswaran G, Narang Y, Zhang T, et al. Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study. American Journal of Preventive Cardiology. 2026;28:101543. doi:10.1016/j.ajpc.2026.101543

BibTeX
@article{Ponnana2026,
  author = {Ponnana, Sai Rahul and Surya, Nik and Presswalla, Feriel and Parameswaran, Gokul and Narang, Yuvraj and Zhang, Tong and Chen, Zhuo and Dazard, Jean-Eudes and Sirasapalli, Santosh Kumar and Sivanantham, Kanimozhi and Okyere, Robert and Elhussain, Shamsa and Neeland, Ian J and Rajagopalan, Sanjay and Deo, Salil V},
  title = {Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  volume = {28},
  pages = {101543},
  doi = {10.1016/j.ajpc.2026.101543}
}
Kostenlos starten →